Arbidole--a new drug for prevention of influenza and acute viral respiratory infections in children

The antiviral drug arbidole reduces influenza and acute respiratory diseases (ARD) in children by 1.5-2 times when given in a dose of 0.1-0.2 g 2-3 or 5 times a week, by making influenza and ARD milder and decreasing their duration by 1.4-2.8 days. Unified regimens for prophylactic use of arbidole i...

Full description

Saved in:

Bibliographic Details
Published in:	Vestnik Rossiĭskoĭ akademii medits︠i︡nskih nauk no. 8; p. 34
Main Authors:	Beliaev, A L, Burtseva, E I, Slepushkin, A N, Beliaeva, N A, Nosik, N N, Lavrukhina, L A, Maksimova, L N, Feklisova, L V, Shibekova, V M, Danina, N F, Tselipanova, E E, Bylinkina, S A, Voĭtsekhovskaia, E M, Sominina, A A
Format:	Journal Article
Language:	Russian
Published:	Russia (Federation) 1996
Subjects:	Adolescent Antiviral Agents - therapeutic use Child Female Humans Indoles - therapeutic use Influenza, Human - prevention & control Male Respiratory Tract Infections - prevention & control Respiratory Tract Infections - virology Treatment Outcome Virus Diseases - prevention & control
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The antiviral drug arbidole reduces influenza and acute respiratory diseases (ARD) in children by 1.5-2 times when given in a dose of 0.1-0.2 g 2-3 or 5 times a week, by making influenza and ARD milder and decreasing their duration by 1.4-2.8 days. Unified regimens for prophylactic use of arbidole in influenza and ARD in children and adults are proposed.
ISSN:	0869-6047